SCHEMBL8937021

SCHEMBL8937021

C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NMT2 O60551 1/20 0.43
▸ NMT1 P30419 1/20 0.43
▸ FURIN P09958 5/20 0.43
▸ NPY4R P50391 7/20 0.41
▸ NPY1R P25929 4/20 0.41
▸ NPY2R P49146 4/20 0.41
▸ NPY5R Q15761 4/20 0.41
▸ SLC15A2 Q16348 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8937002 1.00 NMT2 (0.43) NMT2NMT1FURINNPY4RNPY1R
SCHEMBL31085370 0.90 NPY4R (0.50) NPY4RNPY1RNPY2RNPY5R
SCHEMBL30423518 0.89 NPY4R (0.50) NMT2NMT1FURINNPY4RNPY1R
SCHEMBL30373028 0.88 SLC15A2 (0.51) NMT2NMT1NPY4RNPY1RNPY2R
SCHEMBL30372694 0.88 SLC15A2 (0.51) NMT2NMT1NPY4RNPY1RNPY2R
SCHEMBL31106970 0.88 SLC15A2 (0.51) NMT2NMT1NPY4RNPY1RNPY2R
SCHEMBL29461533 0.88 SLC15A2 (0.51) NMT2NMT1NPY4RNPY1RNPY2R
SCHEMBL5598706 0.88 SLC15A2 (0.51) NMT2NMT1NPY4RNPY1RNPY2R
SCHEMBL31717990 0.88 SLC15A2 (0.51) NMT2NMT1NPY4RNPY1RNPY2R
SCHEMBL30713830 0.88 SLC15A2 (0.51) NMT2NMT1NPY4RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0673384-A4 POLYPEPTIDES USEFUL FOR TREATING INFLAMMATORY DISORDERS. UNIV MINNESOTA (US) 1996-10-09 — — EP claimed
EP-0673384-A1 POLYPEPTIDES USEFUL FOR TREATING INFLAMMATORY DISORDERS THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1995-09-27 — — EP claimed
WO-1994013692-A1 POLYPEPTIDES USEFUL FOR TREATING INFLAMMATORY DISORDERS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1994-06-23 — — WO claimed
Send feedback